At a glance
- Originator Roche
- Class Anti-inflammatories; Antirheumatics
- Mechanism of Action Protein kinase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders
Most Recent Events
- 09 Nov 2006 Discontinued - Preclinical for Rheumatic disorders in Switzerland (unspecified route)
- 09 Nov 2006 Discontinued - Preclinical for Rheumatic disorders in USA (unspecified route)